HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 575333Generated: October 27, 2026
1-Boc-3-methylpyrazole-5-boronic acid → HCID 178422860, compound
https://huagongshe.com/reaction/575333
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Boc-3-methylpyrazole-5-boronic acid | HCID 53216326 | — |
| Reactant | 10-Bromo-9-fluoro-3-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide | HCID 86693052 | — |
| Product | HCID 178422860 | HCID 178422860 | — |
Reaction Steps
10-bromo-9-fluoro-3-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide was reacted with (2-tert-butoxycarbonyl-5-methyl-pyrazol-3-yl)boronic acid similarly to as described in Example 4 to produce crude 10-bromo-9-fluoro-3-(3-methyl-1H-pyrazol-5-yl)-5,6dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide. 10-bromo-9-fluoro-3-(3-methyl-1H-pyrazol-5-yl)-5,6dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide was reacted with (2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)but-3-yn-2-ol via General Procedure E to afford 5.8 mg (6.6%) 9-fluoro-10-[(3R)-3-hydroxy-3-(5-methyl-1,2,4-oxadiazol-3-yl)but-1-ynyl]-3-(3-methyl-1H-pyrazol-5-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-2-carboxamide following reverse phase purification. M+1=478.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09034866B2 |
|---|
| Source dataset | uspto-grants-2015_05 |
|---|
| ORD ID | ord-8b867d954fd84defad3880003ea44bd5 |
|---|
| Source note | uspto-grants-2015_05 |
|---|